Health ASA: Hold GLP-1 Agonists Before Elective Surgery Eli Pacheco Jun 30, 2023 0 Patients on GLP-1 receptor agonists should stop taking them prior to elective…
Health Black Patients With Overactive Bladder Less Likely to Receive β3-Adrenoceptor… Eli Pacheco May 27, 2023 0 Lori Solomon FRIDAY, May 26, 2023 (HealthDay News) -- Black individuals are significantly less likely than non-Hispanic White individuals to…
Health Melanocortin Agonists Market to Hit a Revenue CAGR of 5.9% During the Forecast Period… Eli Pacheco May 18, 2023 0 <!-- Name:DistributionId Value:8842134 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Health GLP-1 Agonists Come Out on Top in Cardiovascular Comparison of Newer Diabetes Meds Eli Pacheco May 9, 2023 0 Diabetes patients adding a newcomer drug to their medications may derive cardiovascular…
Health Diabetes Patients Also Struggle to Access GLP-1 Agonists Eli Pacheco Jan 25, 2023 0 Last fall, Jody Dushay, MD, an endocrinologist at Beth Israel Deaconess Medical Center in…
Health GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder? Eli Pacheco Mar 28, 2022 0 A certain class of antidiabetic agent was linked with gallbladder and biliary diseases,…
Health Use of GLP-1 Receptor Agonists Scarce in Type 2 Diabetes Eli Pacheco Dec 18, 2021 0 Access to a certain class of diabetes agents might not be equitable across all patients, a…
Health Diabetes medications linked to glaucoma prevention: Retrospective data from more than… Eli Pacheco Sep 21, 2021 0 A popular class of diabetes medications called GLP-1R agonists (Trulicity and Rybelsus) may also protect against glaucoma in diabetic patients, according to a new study led by researchers in…